310 related articles for article (PubMed ID: 19733596)
1. Wanted, dead or alive: new viral vaccines.
Amanna IJ; Slifka MK
Antiviral Res; 2009 Nov; 84(2):119-30. PubMed ID: 19733596
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.
Mok DZL; Chan KR
Viruses; 2020 May; 12(5):. PubMed ID: 32397218
[TBL] [Abstract][Full Text] [Related]
3. Immunological memory to viral infection.
Slifka MK
Curr Opin Immunol; 2004 Aug; 16(4):443-50. PubMed ID: 15245737
[TBL] [Abstract][Full Text] [Related]
4. Antibodies, viruses and vaccines.
Burton DR
Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
[TBL] [Abstract][Full Text] [Related]
5. Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High T
Eldi P; Chaudhri G; Nutt SL; Newsome TP; Karupiah G
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626686
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
Robert Putnak J; Coller BA; Voss G; Vaughn DW; Clements D; Peters I; Bignami G; Houng HS; Chen RC; Barvir DA; Seriwatana J; Cayphas S; Garçon N; Gheysen D; Kanesa-Thasan N; McDonell M; Humphreys T; Eckels KH; Prieels JP; Innis BL
Vaccine; 2005 Aug; 23(35):4442-52. PubMed ID: 16005749
[TBL] [Abstract][Full Text] [Related]
7. Protective and disease-enhancing immune responses to respiratory syncytial virus.
Anderson LJ; Heilman CA
J Infect Dis; 1995 Jan; 171(1):1-7. PubMed ID: 7798649
[TBL] [Abstract][Full Text] [Related]
8. Measles-derived vaccines to prevent emerging viral diseases.
Frantz PN; Teeravechyan S; Tangy F
Microbes Infect; 2018; 20(9-10):493-500. PubMed ID: 29410084
[TBL] [Abstract][Full Text] [Related]
9. Hatchery Vaccination Against Poultry Viral Diseases: Potential Mechanisms and Limitations.
Abdul-Cader MS; Palomino-Tapia V; Amarasinghe A; Ahmed-Hassan H; De Silva Senapathi U; Abdul-Careem MF
Viral Immunol; 2018; 31(1):23-33. PubMed ID: 28714781
[TBL] [Abstract][Full Text] [Related]
10. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
11. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
12. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient.
Kamboj M; Sepkowitz KA
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):702-7. PubMed ID: 17520544
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia-based vaccines to biothreat and emerging viruses.
Nagata LP; Irwin CR; Hu WG; Evans DH
Biotechnol Genet Eng Rev; 2018 Apr; 34(1):107-121. PubMed ID: 29779454
[TBL] [Abstract][Full Text] [Related]
14. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
15. [Modern methods for the development of antiviral vaccines].
Raadsen MP; van Leeuwen LPM; van Gorp ECM; de Swart RL; Haagmans BL
Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030319
[TBL] [Abstract][Full Text] [Related]
16. Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.
Bowick GC; McAuley AJ
Bioeng Bugs; 2011; 2(3):129-35. PubMed ID: 21637006
[TBL] [Abstract][Full Text] [Related]
17. Live attenuated vaccines: Historical successes and current challenges.
Minor PD
Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107
[TBL] [Abstract][Full Text] [Related]
18. Immunity to viruses: learning from successful human vaccines.
Pulendran B; Oh JZ; Nakaya HI; Ravindran R; Kazmin DA
Immunol Rev; 2013 Sep; 255(1):243-55. PubMed ID: 23947360
[TBL] [Abstract][Full Text] [Related]
19. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine.
Levin MJ; Murray M; Zerbe GO; White CJ; Hayward AR
J Infect Dis; 1994 Sep; 170(3):522-6. PubMed ID: 8077709
[TBL] [Abstract][Full Text] [Related]
20. [Theoretical and applied problems of vaccinal prophylaxis of acute viral infections].
Smorodintsev AA; Maĭorova LP
Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):8-13. PubMed ID: 6207692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
